Securing the supply chain 2024

Supply chain sourcing and sustainability strategies for cell therapy and advanced biomaterial products

Cell & Gene Therapy Insights 2024; 10(10), 1371–1376

DOI: 10.18609/cgti.2024.157

Published: 4 November
Interview
Raj Joshi


Abi Pinchbeck, Editor, Cell & Gene Therapy Insights, spoke to Raj Joshi, Head of Supply Chain and Strategic Sourcing, Celularity. As demand for human placental tissue and cord blood rises, Raj emphasizes the need for ethical donor engagement, fostering strong relationships with tissue providers, and implementing risk mitigation strategies. Other critical supply chain bottlenecks are explored in the discussion, including shortages of raw and starting materials and logistical challenges in maintaining temperature-sensitive products at cryogenic temperatures.